Issue: Vol. 4, No. 7, May 12, 2017
Go Back to Medtech Strategist Issue Archive
Table of Contents – The MedTech Strategist, Vol. 4, No. 7, May 12, 2017 (48 Pages):
Perspective—“BD/Bard: Building Critical Mass in a Cost-Constrained World,” by David Cassak & Mary Thompson (Vol. 4, No. 7, May 12, 2017)
Executive Interview—“J&J’s New Approach to Medtech Innovation: An Interview with Bruce Rosengard,” by Stephen Levin (Vol. 4, No. 7, May 12, 2017)
Venture Capital—“Santé Ventures: Investing with a Provider’s Mindset,” by David Cassak
Orthopedics/Extremities—“Cartiva’s Challenge: Moving the Market with a First-in-Class Motion-Preserving Toe Implant,” by Wendy Diller
Quarterly M&A/Financings—“First Quarter Deal-Making Remains Stable, But IPO Window Still Closed,” by Stephen Levin
Start-Ups to Watch—“Flow Forward Medical: A Game-Changer for Hemodialysis Vascular Access,” by Mary Stuart
Start-Ups to Watch—“Linear Health Sciences: The Worry-Free Future of the IV,” by Colin Miller, Contributor